This paper describes agent-based models of epidemics dynamics, willingly simplified with the goal not to predict the evolution of the epidemics, but to explain the underlying mechanisms in an interactive way. They allow to compare screening prioritization strategies, and vaccination priority strategies, on a virtual population. The models are implemented in Netlogo in two simulators, published online at https://nausikaa.net/index.php/simulating-epidemics/ to let people experiment. This paper reports on model design, implementation, and experimentations. We have compared screening strategies to assess the epidemics versus control it by quarantining infectious people; and we have compared vaccinating older people with more risk factors, versus younger people with more social contacts.
Nieves-CuervoGMManrique-HernándezEFRobledo-ColoniaAF, et al. Infodemic: fake news and COVID-19 mortality trends in six Latin American countries. Pan Am J Publ Health2021; 45: e44.
3.
DalyMJonesARobinsonE. Public trust and willingness to vaccinate against COVID-19 in the US from October 14, 2020, to March 29, 2021. JAMA2021; 325: 2397–2399.
4.
JenningsWStokerGBuntingH, et al. Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines2021; 9: 593.
HaweGICoatesGWilsonDT, et al. Agent-based simulation for large-scale emergency response: a survey of usage and implementation. ACM Comput Surv2012; 45: 1–51.
DrogoulATaillandierPGaudouB, et al. Designing social simulation to (seriously) support decision-making: COMOKIT, an agent-based modelling toolkit to analyse and compare the impacts of public health interventions against COVID-19, 2020, https://hal.science/hal-02968321/document
10.
GaudouBHuynhNQPhilipponD, et al. COMOKIT: a modeling kit to understand, analyze, and compare the impacts of mitigation policies against the COVID-19 epidemic at the scale of a city. Front Publ Health2020; 8: 563247.
TaillandierFAdamC. Games ready to use: a serious game for teaching natural risk management. Simul Gam2018; 49: 441–470.
13.
AtalanA. Is the lockdown important to prevent the COVID-19 pandemic? Effects on psychology, environment and economy-perspective. Ann Med Surg2020; 56: 38–42.
14.
TreibelTAManistyCBurtonM, et al. COVID-19: PCR screening of asymptomatic health-care workers at London hospital. Lancet2020; 395: 1608–1610.
15.
RezapourASouresrafilAPeighambariMM, et al. Economic evaluation of programs against COVID-19: a systematic review. Int J Surg2021; 85: 10–18.
16.
JordanREAdabPChengK. COVID-19: risk factors for severe disease and death. BMJ2020; 368: m1198.
17.
HodgsonSHMansattaKMallettG, et al. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis2021; 21: e26–e35.
18.
LipsitchMKahnR. Interpreting vaccine efficacy trial results for infection and transmission. Vaccine2021; 39: 4082–4088.
19.
BleierBSRamanathanMJrLaneAP. COVID-19 vaccines may not prevent nasal SARS-CoV-2 infection and asymptomatic transmission. Otolaryngol Head Neck Surg2021; 164: 305–307.
20.
BianLGaoQGaoF, et al. Impact of the Delta variant on vaccine efficacy and response strategies. Exp Rev Vaccine2021; 20: 1201–1209.
21.
StarkeKRPetereit-HaackGSchubertM, et al. The age-related risk of severe outcomes due to COVID-19 infection: a rapid review, meta-analysis, and meta-regression. Int J Environ Res Publ Health2020; 17: 5974.
22.
EjazHAlsrhaniAZafarA, et al. COVID-19 and comorbidities: deleterious impact on infected patients. J Infect Publ Health2020; 13: 1833–1839.
23.
BajgainKTBadalSBajgainBB, et al. Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature. Am J Infect Control2021; 49: 238–246.
24.
ElezkurtajSGreuelSIhlowJ, et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci Rep2021; 11: 1–9.
25.
IbukaYOhkusaYSugawaraT, et al. Social contacts, vaccination decisions and influenza in Japan. J Epidemiol Commun Health2016; 70: 162–167.
DolginE. COVID vaccine immunity is waning —how much does that matter?Nature2021; 597: 606–607.
28.
GirumTLentiroKGeremewM, et al. Global strategies and effectiveness for COVID-19 prevention through contact tracing, screening, quarantine, and isolation: a systematic review. Trop Med Health2020; 48: 1–15.
29.
JerbiAMasmoudiF. Simulation modeling assessment and improvement of a COVID-19 mass vaccination center operations. Simulation2022; 2022: 1135214.
30.
ErkaymanBAkFÇodurS. A simulation approach for COVID-19 pandemic assessment based on vaccine logistics, SARS-CoV-2 variants, and spread rate. Simulation2023; 99: 127–135.
31.
ChapuisKTaillandierPGaudouB, et al. Using the COMOKIT model to study the impact of the morpho-functional organization of cities on the spread of COVID-19, 2021, https://hal.science/hal-03226688/document
32.
KerrCCStuartRMMistryD, et al. Covasim: an agent-based model of COVID-19 dynamics and interventions. PLoS Comput Biol2021; 17:1009149.
33.
PaltielADZhengAWalenskyRP. Assessment of SARS-CoV-2 screening strategies to permit the safe reopening of college campuses in the United States. JAMA Netw Open2020; 3: e2016818.
HornseyMJHarrisEAFieldingKS. The psychological roots of anti-vaccination attitudes: a 24-nation investigation. Health Psychol2018; 37: 307–315.
36.
LiJGiabbanelliP. Returning to a normal life via COVID-19 vaccines in the United States: a large-scale agent-based simulation study. JMIR Med Inform2021; 9: e27419.
37.
TatapudiHDasRDasT. Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States. BMC Med Res Methodol2021; 21: 272.
38.
YangCYangYLiY. Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach. PLoS ONE2021; 16: e0261236.
CavanaughAMSpicerKBThoroughmanD, et al. Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination—Kentucky, May–June 2021. Morb Mortal Week Rep2021; 70: 1081–1083.
ColellaVBorovoyRResnickM. Participatory simulations: using computational objects to learn about dynamic systems. In: Proceedings of the CHI ’98 conference summary on human factors in computing systems, Los Angeles, CA, 18–23 April 1998, pp. 9–10. New York: ACM.
